6-mo. Min Eff Dose of Flibanserin: 25 v 50 mg Bid v 50 mg hs v Pbo in Younger Women in NA

This study has been completed.

Study NCT00360243 Information provided by Boehringer Ingelheim Pharmaceuticals

First Received: August 3, 2006 Last Updated: April 24, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Primary Completion Date:	April 2008 (Final data collection date for primary outcome measure)